FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Phoenix

Research Profile

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Abdelbary M A Elhissi; Joanna Giebultowicz; David Phoenix; Anna A Stec; Waqar Ahmed; Mohamed Albed Alhnan; Piotr Wroczynski; Kevin M G Taylor
Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
Sarah R Dennison; Leslie H G Morton; David Phoenix
Effect of amidation on the antimicrobial peptide aurein 2.5 from Australian southern bell frogs.
Sarah R Dennison; Frederick Harris; Tailap Bhatt; Jaipaul Singh; David Phoenix
A theoretical analysis of secondary structural characteristics of anticancer peptides.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Phoenix (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Abdelbary M A Elhissi; Joanna Giebultowicz; David Phoenix; Anna A Stec; Waqar Ahmed; Mohamed Albed Alhnan; Piotr Wroczynski; Kevin M G Taylor
Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
International journal of pharmaceutics 2012;436(1-2):519-26.
2012: Sarah R Dennison; Leslie H G Morton; David Phoenix
Effect of amidation on the antimicrobial peptide aurein 2.5 from Australian southern bell frogs.
Protein and peptide letters 2012;19(6):586-91.
2010: Sarah R Dennison; Frederick Harris; Tailap Bhatt; Jaipaul Singh; David Phoenix
A theoretical analysis of secondary structural characteristics of anticancer peptides.
Molecular and cellular biochemistry 2010;333(1-2):129-35.
2009: Frederick Harris; Sarah R Dennison; David Phoenix
Anionic antimicrobial peptides from eukaryotic organisms.
Current protein & peptide science 2009;10(6):585-606.
2009: Sarah Rachel Dennison; Frederick Harris; Tailap Bhatt; Jaipaul Singh; David Phoenix
The effect of C-terminal amidation on the efficacy and selectivity of antimicrobial and anticancer peptides.
Molecular and cellular biochemistry 2009;332(1-2):43-50.
2009: Sarah R Dennison; Leslie H G Morton; Andrea J Shorrocks; Frederick Harris; David Phoenix
A study on the interactions of Aurein 2.5 with bacterial membranes.
Colloids and surfaces. B, Biointerfaces 2009;68(2):225-30.
2009: Sarah R Dennison; Frederick Harris; David Phoenix
A study on the importance of phenylalanine for aurein functionality.
Protein and peptide letters 2009;16(12):1455-8.
2008: Sarah R Dennison; Young Soo Kim; Hyung Joon Cha; David Phoenix
Investigations into the ability of the peptide, HAL18, to interact with bacterial membranes.
European biophysics journal : EBJ 2008;38(1):37-43.
2008: Sarah R Dennison; Leslie H G Morton; Frederick Harris; David Phoenix
The impact of membrane lipid composition on antimicrobial function of an alpha-helical peptide.
Chemistry and physics of lipids 2008;151(2):92-102.
2007: Sarah R Dennison; Rachael D Baker; Iain Nicholl; David Phoenix
Interactions of cell penetrating peptide Tat with model membranes: a biophysical study.
Biochemical and biophysical research communications 2007;363(1):178-82.
2007: Sarah R Dennison; Frederick Harris; Klaus Brandenburg; David Phoenix
Characterization of the N-terminal segment used by the barley yellow dwarf virus movement protein to promote interaction with the nuclear membrane of host plant cells.
Peptides 2007;28(11):2091-7.
2007: Sarah R Dennison; Leslie H G Morton; Frederick Harris; David Phoenix
Antimicrobial properties of a lipid interactive alpha-helical peptide VP1 against Staphylococcus aureus bacteria.
Biophysical chemistry 2007;129(2-3):279-83.
2007: Sarah R Dennison; Frederick Harris; David Phoenix
The interactions of aurein 1.2 with cancer cell membranes.
Biophysical chemistry 2007;127(1-2):78-83.
2007: Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.
Experimental and clinical cardiology 2007;12(1):17-28.
2006: Frederick Harris; Abel Daman; James Wallace; Sarah R Dennison; David Phoenix
Oblique orientated alpha-helices and their prediction.
Current protein & peptide science 2006;7(6):529-37.
2006: Sarah R Dennison; Michelle Whittaker; Frederick Harris; David Phoenix
Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
Current protein & peptide science 2006;7(6):487-99.
2006: David Phoenix; Frederick Harris
The multi-purpose amphiphilic alpha-helix--a historical perspective.
Current protein & peptide science 2006;7(6):471-2.
2006: Frederick Harris; Suman Biswas; Jaipaul Singh; Sarah R Dennison; David Phoenix
Calpains and their multiple roles in diabetes mellitus.
Annals of the New York Academy of Sciences 2006;1084():452-80.
2006: Christos Kalofoutis; Christina Piperi; Aikaterini Zisaki; Jaipaul Singh; Fred Harris; David Phoenix; Antonis Alaveras; Anastasios Kalofoutis
Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different age.
Annals of the New York Academy of Sciences 2006;1084():166-77.
2006: Sarah R Dennison; Jörg Howe; Leslie H G Morton; Klaus Brandenburg; Frederick Harris; David Phoenix
Interactions of an anionic antimicrobial peptide with Staphylococcus aureus membranes.
Biochemical and biophysical research communications 2006;347(4):1006-10.
2006: Sarah R Dennison; Leslie H G Morton; Klaus Brandenburg; Frederick Harris; David Phoenix
Investigations into the ability of an oblique alpha-helical template to provide the basis for design of an antimicrobial anionic amphiphilic peptide.
The FEBS journal 2006;273(16):3792-803.
2006: David Phoenix; Frederick Harris
Light activated compounds as antimicrobial agents - patently obvious?
Recent patents on anti-infective drug discovery 2006;1(2):181-99.
2006: Saimah Hussain; Frederick Harris; David Phoenix
The phototoxicity of phenothiazinium-based photosensitizers to bacterial membranes.
FEMS immunology and medical microbiology 2006;46(1):124-30.
2006: Sarah R Dennison; Thomas Hauss; Silvia Dante; Klaus Brandenburg; Frederick Harris; David Phoenix
Deuteration can affect the conformational behaviour of amphiphilic alpha-helical structures.
Biophysical chemistry 2006;119(2):115-20.
2006: Frederick Harris; Sarah R Dennison; David Phoenix
The prediction of hydrophobicity gradients within membrane interactive protein alpha-helices using a novel graphical technique.
Protein and peptide letters 2006;13(6):595-600.
2005: Kunfan Liu; Zongliang Xia; Yan Zhang; Yuxiang Wen; Daowen Wang; Klaus Brandenburg; Frederick Harris; David Phoenix
Interaction between the movement protein of barley yellow dwarf virus and the cell nuclear envelope: role of a putative amphiphilic alpha-helix at the N-terminus of the movement protein.
Biopolymers 2005;79(2):86-96.
2005: Suman Biswas; Frederick Harris; Sarah Dennison; Jai Paul Singh; David Phoenix
Calpains: enzymes of vision?
Medical science monitor : international medical journal of experimental and clinical research 2005;11(9):RA301-10.
2005: Frederick Harris; Lee Chatfield; David Phoenix
Phenothiazinium based photosensitisers--photodynamic agents with a multiplicity of cellular targets and clinical applications.
Current drug targets 2005;6(5):615-27.
2005: Onkabetse A Daman; James Wallace; Frederick Harris; David Phoenix
An investigation into the ability to define transmembrane protein spans using the biophysical properties of amino acid residues.
Molecular and cellular biochemistry 2005;275(1-2):189-97.
2005: Sarah R Dennison; Silvia Dante; Thomas Hauss; Klaus Brandenburg; Frederick Harris; David Phoenix
Investigations into the membrane interactions of m-calpain domain V.
Biophysical journal 2005;88(4):3008-17.
2005: Zia Sayed; Frederick Harris; David Phoenix
A study on the bacterial photo-toxicity of phenothiazinium based photosensitisers.
FEMS immunology and medical microbiology 2005;43(3):367-72.
2005: Sarah R Dennison; James Wallace; Frederick Harris; David Phoenix
Amphiphilic alpha-helical antimicrobial peptides and their structure/function relationships.
Protein and peptide letters 2005;12(1):31-9.
2005: Sarah R Dennison; Frederick Harris; David Phoenix
Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion?
Protein and peptide letters 2005;12(1):27-9.
2004: Suman Biswas; Frederick Harris; Jaipaul Singh; David Phoenix
The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017.
Molecular and cellular biochemistry 2004;261(1-2):169-73.
2004: Frederick Harris; Lee Chatfield; Jaipaul Singh; David Phoenix
Role of calpains in diabetes mellitus: a mini review.
Molecular and cellular biochemistry 2004;261(1-2):161-7.
2004: Suman Biswas; Frederick Harris; Jaipaul Singh; David Phoenix
Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review.
Molecular and cellular biochemistry 2004;261(1-2):151-9.
2004: Suman Biswas; Frederick Harris; Sarah R Dennison; Jaipaul Singh; David Phoenix
Calpains: targets of cataract prevention?
Trends in molecular medicine 2004;10(2):78-84.
2004: James Wallace; Onkabetse A Daman; Frederick Harris; David Phoenix
Investigation of hydrophobic moment and hydrophobicity properties for transmembrane alpha-helices.
Theoretical biology & medical modelling 2004;1():5.
2003: James Wallace; Frederick Harris; David Phoenix
A statistical investigation of amphiphilic properties of C-terminally anchored peptidases.
European biophysics journal : EBJ 2003;32(7):589-98.
2003: David Phoenix; Z Sayed; S Hussain; Frederick Harris; Mark Wainwright
The phototoxicity of phenothiazinium derivatives against Escherichia coli and Staphylococcus aureus.
FEMS immunology and medical microbiology 2003;39(1):17-22.
2003: Sarah R Dennison; Frederick Harris; David Phoenix
Factors determining the efficacy of alpha-helical antimicrobial peptides.
Protein and peptide letters 2003;10(5):497-502.
2003: David Phoenix; Frederick Harris
Is use of the hydrophobic moment a sound basis for predicting the structure-function relationships of membrane interactive alpha-helices?
Current protein & peptide science 2003;4(5):357-66.
2003: David Phoenix; Frederick Harris
Phenothiazinium-based photosensitizers: antibacterials of the future?
Trends in molecular medicine 2003;9(7):283-5.
2002: Frederick Harris; Klaus Brandenburg; Ulrich Seydel; David Phoenix
Investigations into the mechanisms used by the C-terminal anchors of Escherichia coli penicillin-binding proteins 4, 5, 6 and 6b for membrane interaction.
European journal of biochemistry / FEBS 2002;269(23):5821-9.
2002: Klaus Brandenburg; Frederick Harris; Sarah Dennison; Ulrich Seydel; David Phoenix
Domain V of m-calpain shows the potential to form an oblique-orientated alpha-helix, which may modulate the enzyme's activity via interactions with anionic lipid.
European journal of biochemistry / FEBS 2002;269(22):5414-22.
2002: SM Burrow; David Phoenix; Mark Wainwright; M J Tobin
Intracellular localisation studies of doxorubicin and Victoria Blue BO in EMT6-S and EMT6-R cells using confocal microscopy.
Cytotechnology 2002;39(1):15-25.
2002: David Phoenix; Frederick Harris; Onkabetse A Daman; James Wallace
The prediction of amphiphilic alpha-helices.
Current protein & peptide science 2002;3(2):201-21.
2002: Frederick Harris; Lee Chatfield; David Phoenix
The gene genie?
Biologist (London, England) 2002;49(1):25-8.
2002: K Brandenburg; F Harris; David Phoenix; U Seydel
A study on the C-terminal membrane anchoring of Escherichia coli penicillin-binding protein 5.
Biochemical and biophysical research communications 2002;290(1):427-30.
2002: David Phoenix; Frederick Harris
The hydrophobic moment and its use in the classification of amphiphilic structures (review).
Molecular membrane biology 2002;19(1):1-10.
2001: S Biswas; F Harris; David Phoenix
Treatment of cataracts - vision for the future.
Biologist (London, England) 2001;48(6):273-7.
2001: Mark Wainwright; David Phoenix; T E Smillie; D R A Wareing
Phenothiaziniums as putative photobactericidal agents for red blood cell concentrates.
Journal of chemotherapy (Florence, Italy) 2001;13(5):503-9.
2001: David Phoenix; Klaus Brandenburg; Frederick Harris; U Seydel; T Hammerton; I S Roberts
An investigation into the membrane-interactive potential of the Escherichia coli KpsE C-terminus.
Biochemical and biophysical research communications 2001;285(4):976-80.
2001: A Daman; Frederick Harris; Suman Biswas; James Wallace; David Phoenix
A theoretical investigation into the lipid interactions of m-calpain.
Molecular and cellular biochemistry 2001;223(1-2):159-63.
2000: Frederick Harris; J Wallace; David Phoenix
Use of hydrophobic moment plot methodology to aid the identification of oblique orientated alpha-helices.
Molecular membrane biology 2000;17(4):201-7.
2000: Frederick Harris; Lee Chatfield; David Phoenix
The magic bullet?
Biologist (London, England) 2000;47(3):164.
2000: SM Burrow; David Phoenix; Mark Wainwright; JJ Waring
Reduced cellular glutathione levels do not affect the cytotoxicity or photocytotoxicity of the cationic photosensitiser Victoria Blue BO.
Membrane & cell biology 2000;14(3):357-66.
1999: Mark Wainwright; David Phoenix; M Gaskell; B Marshall
Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp.
The Journal of antimicrobial chemotherapy 1999;44(6):823-5.
1999: Mark Wainwright; David Phoenix; SM Burrow; J Waring
Cytotoxicity and adjuvant activity of cationic photosensitizers in a multidrug resistant cell line.
Journal of chemotherapy (Florence, Italy) 1999;11(1):61-8.
1999: Maria B Chaley; Eugene V Korotkov; David Phoenix
Relationships among isoacceptor tRNAs seems to support the coevolution theory of the origin of the genetic code.
Journal of molecular evolution 1999;48(2):168-77.
1999: Mark Wainwright; SM Burrow; S G Guinot; David Phoenix; J Waring
Uptake and cell-killing activities of a series of Victoria blue derivatives in a mouse mammary tumour cell line.
Cytotechnology 1999;29(1):35-43.
1998: Frederick Harris; R Demel; B de Kruijff; David Phoenix
An investigation into the lipid interactions of peptides corresponding to the C-terminal anchoring domains of Escherichia coli penicillin-binding proteins 4, 5 and 6.
Biochimica et biophysica acta 1998;1415(1):10-22.
1998: L Rice; David Phoenix; Mark Wainwright; JJ Waring
Effect of increasing methylation on the ability of methylene blue to cause diaphorase-catalysed oxidation of NADH.
Biochemical Society transactions 1998;26(4):S319.
1998: Frederick Harris; A Wiese; K Brandenberg; David Phoenix; U Seydel
An investigation into the lipid interactions of peptides corresponding to the C-terminal anchoring domains of Escherichia coli penicillin-binding proteins 4 and 5.
Biochemical Society transactions 1998;26(3):S296.
1998: R Swan; I Kimberley; David Phoenix
Use of cross-linking to investigate protein interactions with E. coli penicillin binding protein 4.
Biochemical Society transactions 1998;26(3):S295.
1998: Mark Wainwright; David Phoenix; J Marland; D R A Wareing; Frederick J Bolton
A comparison of the bactericidal and photobactericidal activities of aminoacridines and bis(aminoacridines).
Letters in applied microbiology 1998;26(6):404-6.
1998: Mark Wainwright; David Phoenix; S L Laycock; D R A Wareing; P A Wright
Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus.
FEMS microbiology letters 1998;160(2):177-81.
1998: David Phoenix; A Stanworth; Frederick Harris
The hydrophobic moment plot and its efficacy in the prediction and classification of membrane interactive proteins and peptides.
Membrane & cell biology 1998;12(1):101-10.
1998: Frederick Harris; David Phoenix
The Escherichia coli low molecular mass penicillin-binding proteins and a putative membrane bound protein complex.
Membrane & cell biology 1998;11(5):591-6.
1997: G Siligardi; Frederick Harris; David Phoenix
Alpha-helical conformation in the C-terminal anchoring domains of E. coli penicillin-binding proteins 4, 5 and 6.
Biochimica et biophysica acta 1997;1329(2):278-84.
1997: Mark Wainwright; David Phoenix; L Rice; SM Burrow; J Waring
Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation.
Journal of photochemistry and photobiology. B, Biology 1997;40(3):233-9.
1997: Mark Wainwright; David Phoenix; J Marland; D R A Wareing; Frederick J Bolton
In-vitro photobactericidal activity of aminoacridines.
The Journal of antimicrobial chemotherapy 1997;40(4):587-9.
1997: David Phoenix; Eugene V Korotkov
Evidence of rare codon clusters within Escherichia coli coding regions.
FEMS microbiology letters 1997;155(1):63-6.
1997: Mark Wainwright; David Phoenix; J Marland; D R A Wareing; Frederick J Bolton
A study of photobactericidal activity in the phenothiazinium series.
FEMS immunology and medical microbiology 1997;19(1):75-80.
1997: Frederick Harris; David Phoenix
An investigation into the ability of C-terminal homologues of Escherichia coli low molecular mass penicillin-binding proteins 4, 5 and 6 to undergo membrane interaction.
Biochimie 1997;79(4):171-4.
1997: M G Roberts; David Phoenix; A R Pewsey
An algorithm for the detection of surface-active alpha helices with the potential to anchor proteins at the membrane interface.
Computer applications in the biosciences : CABIOS 1997;13(1):99-106.
1997: J S Tulko; Eugene V Korotkov; David Phoenix
MIRs are present in coding regions of human genes.
DNA sequence : the journal of DNA sequencing and mapping 1997;8(1-2):31-8.
1997: Eugene V Korotkov; David Phoenix
Latent periodicity of DNA sequences of many genes.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 1997;():222-31.
1996: David Phoenix
On the targeting and membrane assembly of the Escherichia coli outer membrane porin, PhoE.
FEMS immunology and medical microbiology 1996;16(2):77-82.
1996: S M Burrow; Carole E Rolph; David Phoenix
Development of a bacterial model for studying anthracycline-membrane interactions.
FEMS microbiology letters 1996;145(2):281-6.
1996: David Phoenix; Eugene V Korotkov
Identification and interpretation of latent periodicity within DNA sequences.
Biochemical Society transactions 1996;24(3):422S.
1995: David Phoenix; Frederick Harris
The membrane-interactive properties of the low-molecular-mass penicillin-binding proteins of Escherichia coli.
Biochemical Society transactions 1995;23(4):976-80.
1995: Frederick Harris; L Chatfield; David Phoenix
The soluble form of Escherichia coli penicillin-binding protein 4 observed in over-expressing strains is an artefact of the system.
Biochemical Society transactions 1995;23(4):563S.
1995: Frederick Harris; L Chatfield; David Phoenix
Using beta-lactams to investigate the existence of a protein complex, involving the Escherichia coli penicillin-binding proteins 1a/1b, 3 and 5.
Biochemical Society transactions 1995;23(4):562S.
1995: David Phoenix; A Pewsey; M G Roberts
Distribution and clustering of rare codons in Escherichia coli genes.
Biochemical Society transactions 1995;23(4):503S.
1995: Frederick Harris; L K Chatfield; David Phoenix
Depletion of anionic phospholipids has no observable effect on the anchoring of penicillin binding protein 5 to the inner membrane of Escherichia coli.
FEMS microbiology letters 1995;129(2-3):215-20.
1995: S M Burrow; S Guinot; Mark Wainwright; J J Waring; David Phoenix
Investigations of a series of novel cationic photosensitisers and their potential use in photodynamic therapy.
Biochemical Society transactions 1995;23(2):260S.
1995: R F Collins; M Roberts; David Phoenix
Codon bias in Escherichia coli may modulate translation initiation.
Biochemical Society transactions 1995;23(1):76S.
1995: M G Roberts; David Phoenix
Comparison of the potential membrane insertion geometry's of Escherichia coli low molecular weight penicillin binding protein anchors.
Biochemical Society transactions 1995;23(1):33S.
1995: Frederick Harris; L Chatfield; David Phoenix
The possible involvement of anionic phospholipids in the anchoring of penicillin binding protein 5 to the inner membrane of Escerichia coli.
Biochemical Society transactions 1995;23(1):32S.
1995: David Phoenix
Investigation into the lipid requirement for the membrane anchoring of Escherichia coli penicillin binding protein 5.
Biochemical Society transactions 1995;23(1):31S.
1994: S M Burrow; Carole E Rolph; J J Waring; David Phoenix
Development of a prokaryotic model for studying anthracycline-membrane interactions.
Biochemical Society transactions 1994;22(4):397S.
1994: David Phoenix; S E Peters; M A Ramzan; J M Pratt
Analysis of the membrane-anchoring properties of the putative amphiphilic alpha-helical anchor at the C-terminus of Escherichia coli PBP 6.
Microbiology (Reading, England) 1994;140 ( Pt 1)():73-7.
1994: J R Gittins; David Phoenix; J M Pratt
Multiple mechanisms of membrane anchoring of Escherichia coli penicillin-binding proteins.
FEMS microbiology reviews 1994;13(1):1-12.
1993: David Phoenix
The energetics of prePhoE translocation.
Biochemical Society transactions 1993;21(4):341S.
1993: David Phoenix; R Kusters; C Hikita; S Mizushima; Ben de Kruijff
OmpF-Lpp signal sequence mutants with varying charge hydrophobicity ratios provide evidence for a phosphatidylglycerol-signal sequence interaction during protein translocation across the Escherichia coli inner membrane.
The Journal of biological chemistry 1993;268(23):17069-73.
1993: David Phoenix
Identification of a membrane interactive protein anchor.
Biochemical Society transactions 1993;21 ( Pt 3)(3):225S.
1993: David Phoenix; F A de Wolf; W H Staffhorst; C Hikita; S Mizushima; Ben de Kruijff
Phosphatidylglycerol dependent protein translocation across the Escherichia coli inner membrane is inhibited by the anti-cancer drug doxorubicin. Evidence for an electrostatic interaction between the signal sequence and phosphatidylglycerol.
FEBS letters 1993;324(1):113-6.
1993: David Phoenix; J M Pratt
Membrane interaction of Escherichia coli penicillin binding protein 5 is modulated by the ectomembranous domain.
FEBS letters 1993;322(3):215-8.
1990: David Phoenix
Investigation into structural features of the Escherichia coli penicillin-binding protein 5 C-terminal anchor.
Biochemical Society transactions 1990;18(5):948-9.
1990: David Phoenix; J M Pratt
pH-induced insertion of the amphiphilic alpha-helical anchor of Escherichia coli penicillin-binding protein 5.
European journal of biochemistry / FEBS 1990;190(2):365-9.